Skip Navigation

Faculty Search Results

  New Search


Faculty Search Results: Results 1 - 20 (List more/fewer results: 10 20 30 40 )
Faculty Member Brief Research Description
Mohammad Fallahi-Sichani Our research is at the interface of bioengineering, cancer biology and quantitative pharmacology and combines experimental methods and data-driven computational approaches with the goal of understanding oncogenic signaling and therapeutic mechanisms in human tumors.  
Dr. Xing Fan Study signaling pathways that regulate brain development and tumor formation to develop novel therapy targeting brain cancer stem cells.  
Eric Fearon Studies of oncogene and tumor suppressor gene defects in cancer pathogenesis, particularly gastrointestinal cancers.  
Eva Feldman I am interested in understanding the pathogenic mechanisms underlying neurodegeneration in the central and peripheral nervous systems and identifying effective therapies.  
David Ferguson The Ferguson laboratory studies how mammalian cells maintain a stable genome. The proteins that accomplish this serve to prevent cancer and ensure proper functioning of the immune system. Currently, our main focus is a multi-protein complex called MRN, which is mutated in human cancer predisposition and immunodeficiency syndromes. For more information see the lab website at: http://www.pathology.med.umich.edu/fergusonlab/index.html  
Carrie Ferrario We aim to understand the neural mechanisms underling drug addiction and obesity in order to develop prevention and treatment strategies.  
Diane Fingar Regulation and function of signal transduction by mTOR complexes  
David Fink Our research is directed at the development of gene transfer therapies for diseases of the nervous system. We use recombinant replication-defective vectors created by modification of herpes simplex virus to deliver and express transgenes in central and peripheral nervous system in models of pain, peripheral neuropathy and spinal cord injury.  
John Fink Genetic analysis of neurologic disorders including gene discovery and creation of vertebrate and invertebrate models. We are particularly interested in the molecular mechanisms of axon degeneration.  
Stephen Fisher   
Shelly Flagel Interested in understanding the behavioral and neurobiological processes that contribute to individual differences in stimulus-reward learning and addiction liability.  
Daniel Forger My research is devoted to understanding biological clocks. I use techniques from many fields, including computer simulation, detailed mathematical modeling and mathematical analysis, to understand biological timekeeping. My research aims to generate predictions that can be experimentally verified.  
Patrice Fort Regulation of intrinsic neuroprotective mechanisms in neurodegenerative diseases (Diabetic Retinopathy and others) - Implication of Crystallin proteins and their post-translational modifications.  
David Fox Research in Dr. Fox's laboratory is directed at defining and characterizing pathways of human T cell activation, and the role of these pathways in the pathogenesis of autoimmune disease.  
Renny Franceschi Transcriptional control of mesenchymal cell lineage to bone or fat, role of the Runx2 transcription factor in prostate cancer and cancer stem cells.  
Aaron Frank   
Peter Freddolino Combining high-throughput experimental measurements with multiscale modeling to understand and simulate regulatory networks  
Christine Freeman My laboratory studies the role of various immune cells in the pathogenesis of chronic obstructive pulmonary disease (COPD).  
A. Oveta Fuller An innovative biology-based HIV/AIDS prevention intervention through faith leader networks Mechanisms of entry and membrane fusion of human viral pathogens   
Bob Fuller We are interested in the basic cell biology and enzymology of protein localization and processing in the eukaryotic secretory pathway.  
1